Gopalaswamy, R.; Palani, N.; Viswanathan, D.; Preysingh, B.; Rajendran, S.; Vijayaraghavan, V.; Thangavel, K.; Vadivel, S.D.; Stanley, H.; Thiruvengadam, K.;
et al. Resistance Profiles to Second-Line Anti-Tuberculosis Drugs and Their Treatment Outcomes: A Three-Year Retrospective Analysis from South India. Medicina 2023, 59, 1005.
https://doi.org/10.3390/medicina59061005
AMA Style
Gopalaswamy R, Palani N, Viswanathan D, Preysingh B, Rajendran S, Vijayaraghavan V, Thangavel K, Vadivel SD, Stanley H, Thiruvengadam K,
et al. Resistance Profiles to Second-Line Anti-Tuberculosis Drugs and Their Treatment Outcomes: A Three-Year Retrospective Analysis from South India. Medicina. 2023; 59(6):1005.
https://doi.org/10.3390/medicina59061005
Chicago/Turabian Style
Gopalaswamy, Radha, Nandhini Palani, Dinesh Viswanathan, Bershila Preysingh, Suchithra Rajendran, Vaishnavee Vijayaraghavan, Kannadasan Thangavel, Senthil Devi Vadivel, Hannah Stanley, Kannan Thiruvengadam,
and et al. 2023. "Resistance Profiles to Second-Line Anti-Tuberculosis Drugs and Their Treatment Outcomes: A Three-Year Retrospective Analysis from South India" Medicina 59, no. 6: 1005.
https://doi.org/10.3390/medicina59061005
APA Style
Gopalaswamy, R., Palani, N., Viswanathan, D., Preysingh, B., Rajendran, S., Vijayaraghavan, V., Thangavel, K., Vadivel, S. D., Stanley, H., Thiruvengadam, K., Jayabal, L., Murugesan, K., Rathinam, S., Frederick, A., Sivaramakrishnan, G., Padmapriyadarsini, C., & Shanmugam, S.
(2023). Resistance Profiles to Second-Line Anti-Tuberculosis Drugs and Their Treatment Outcomes: A Three-Year Retrospective Analysis from South India. Medicina, 59(6), 1005.
https://doi.org/10.3390/medicina59061005
